[
    [
        {
            "time": "",
            "original_text": "安图生物(603658.SH)：取得”胰岛素样生长因子-1检测试剂盒“医疗器械注册证书",
            "features": {
                "keywords": [
                    "安图生物",
                    "胰岛素样生长因子-1",
                    "检测试剂盒",
                    "医疗器械注册证书"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "安图生物(603658.SH)：取得”胰岛素样生长因子-1检测试剂盒“医疗器械注册证书",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "贝尔生物拟创业板上市：业绩增长较为稳健，商誉减值压力犹存",
            "features": {
                "keywords": [
                    "贝尔生物",
                    "创业板上市",
                    "业绩增长",
                    "商誉减值"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "mixed",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "贝尔生物拟创业板上市：业绩增长较为稳健，商誉减值压力犹存",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "郑州安图生物工程股份有限公司2020年非公开发行股票预案（修订稿）",
            "features": {
                "keywords": [
                    "郑州安图生物",
                    "非公开发行股票",
                    "预案",
                    "修订稿"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "郑州安图生物工程股份有限公司2020年非公开发行股票预案（修订稿）",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]